[Ventricular tachycardia : Treatment and prognostic significance]
Stephanie Fichtner1, Stefan Kääb
1Medizinische Klinik und Poliklinik I, Klinikum Großhadern, Ludwig-Maximilians-Universität München, München, Deutschland, Stephanie.Fichtner@med.uni-muenchen.de.
Insights
Dilative cardiomyopathy and hypertrophic cardiomyopathy increase sudden cardiac death risk. Advanced imaging and genetic testing can improve risk stratification for these heart conditions.
Area of Science:
- Cardiology
- Genetics
- Medical Imaging
Context:
- Dilative cardiomyopathy (DCM) affects 5-8/100,000 people; hypertrophic cardiomyopathy (HCM) affects 1/500.
- Both DCM and HCM carry risks for sudden cardiac death (SCD).
- Current risk stratification for intermediate-risk patients is insufficient, leading to suboptimal cardioverter-defibrillator (ICD) implantation and complications.
Purpose:
- To explore advanced methods for improving risk stratification in patients with DCM and HCM.
- To identify key risk factors for SCD in DCM and HCM.
- To reduce unnecessary ICD implantations and associated complications.
Summary:
- DCM SCD risk factors include reduced ejection fraction and physical capacity.
- HCM SCD risk factors include family history, septum thickness >30mm, syncope, non-sustained VT, and inadequate blood pressure response during exercise.
- Late enhancement cardiac MRI, genetic variation identification, and ECG characteristics can enhance risk stratification.
Impact:
- Improved patient selection for ICD implantation, reducing device-related complications.
- More accurate risk assessment for sudden cardiac death in cardiomyopathy patients.
- Potential for personalized treatment strategies based on advanced risk stratification.
Abstract:
Dilative cardiomyopathy (DCM) has an incidence of 5-8/100,000 inhabitants, and hypertrophic cardiomyopathy an incidence of 1/500 inhabitants. Depending on specific risk factors both conditions have an increased risk for sudden cardiac death (SCD): in DCM reduced left ventricular ejection fraction and reduced physical capacity; and in HCM SCD in family members, left ventricular septum > 30 mm, unclear syncope, non-sustained ventricular tachycardia (VT) on holter-ECG and inadequate blood pressure response on ergometer. Especially patients with intermediary risk factors are insufficiently classified, and the lifesaving implantation of a cardioverter-defibrillator (ICD) often leads to a significant number of device-related complications. In this area additional methods like late enhancement imaging with cardio MRI, identification of genetic variation and ECG characteristics could help improve risk stratification in these patients.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
